iAnthus settles Hi-Med lawsuit by issuing 20M common shares; claim dismissed with prejudice

iANTHUS CAPITAL HOLDINGS, INC.

iAnthus issued 20 million common shares to Hi-Med to settle litigation over a $5M unsecured debenture.
Settlement effective December 12, 2023; Hi-Med will file to dismiss claim with prejudice.
No admission of wrongdoing by iAnthus or its directors/officers.
Shares subject to Canadian four-month-and-one-day holding period; not registered under U.S. Securities Act.
Litigation began June 2020; Hi-Med alleged breaches of debenture and purchase agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.